Global auto injector Market

Auto injector Market Size, Share, Growth Analysis, By Usage (Disposable, Reusable), By Technology (Manual, Automatic), By Route of Administration (Subcutaneous, Intramuscular), By Therapy Area (Rheumatoid Arthritis, Diabetes), By Volume (Up To 3Ml, Above 3Ml), By End User (Home Care Settings, Hospitals & Clinics), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35B2104 | Region: Global | Published Date: November, 2024
Pages: 157 | Tables: 87 | Figures: 76

Auto Injector Market News

  • In May 2023, SHL Medical and MoonLake Immunotherapeutics announced a collaborative partnership to develop the sonelokimab auto injector. This collaboration aims to leverage SHL Medical's expertise in auto injector technology, specifically their Molly auto injector, for the clinical and potential commercial supply of MoonLake's Nanobody sonelokimab. The collaboration between SHL Medical and MoonLake Immunotherapeutics highlights the strategic alliance between two industry leaders to enhance drug delivery systems and provide patients with a user-friendly and efficient auto injector for administering sonelokimab, a promising therapeutic option in immunotherapy.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Autoinjectors Market size was valued at USD 7.16 billion in 2022 and is poised to grow from USD 8.37 billion in 2023 to USD 24.59 billion by 2031, growing at a CAGR of 14.42% during the forecast period (2024-2031).

The competitive landscape of the auto injector market is characterized by a diverse range of players vying for market share and innovation. Established pharmaceutical companies, medical device manufacturers, and specialized auto injector manufacturers are the key participants in this market. These companies focus on product development, strategic collaborations, mergers and acquisitions, and geographical expansion to strengthen their market presence. Additionally, there are several smaller players that specialize in manufacturing niche or customized auto injectors. 'SHL Medical AG ', 'Ypsomed AG ', 'Becton, Dickinson and Company (BD) ', 'EQT IX (Recipharm AB) ', 'West Pharmaceutical Services, Inc. ', 'Molex (Phillips-Medisize) ', 'Halozyme, Inc. ', 'Owen Mumford Ltd. ', 'AbbVie Inc. ', 'Amgen Inc. ', 'Novo Holdings A/S ', 'Johnson & Johnson  ', 'Sanofi ', 'GSK PLC ', 'Gerresheimer AG ', 'Medmix (Haselmaier) ', 'SMC Ltd. (Oval Medical Technologies Ltd.) ', 'Kaléo, Inc. ', 'Solteam Incorporation Co., Ltd. ', 'Elcam Drug Delivery Devices ', 'Crossject ', 'Jabil Inc. ', 'Congruence Medical Solutions LLC ', 'Midas Pharma GmbH'

The rising incidence of chronic diseases, such as rheumatoid arthritis, multiple sclerosis, diabetes, and allergies, is a significant driver of the auto injector market. auto injectors offer a convenient and efficient way for patients to self-administer medications, empowering them to manage their conditions effectively.

The market is witnessing a notable trend towards self-administration of medications. Patients are increasingly seeking greater control and convenience in managing their treatment, leading to a rise in the adoption of auto injectors. These devices allow patients to self-administer medications accurately and easily, empowering them to take an active role in their healthcare journey.

The global auto injector market is segmented based on region, and two significant segments within this market are North America and Asia-Pacific. The largest segment in terms of regional demand is North America, renowned for its advanced healthcare infrastructure and strong focus on patient convenience and self-administration. The region's well-established pharmaceutical and biotechnology industries drive the significant demand for auto injectors. With a rising prevalence of chronic diseases and an aging population, there is a growing need for efficient and user-friendly drug delivery systems. auto injectors offer a reliable and convenient solution, allowing patients to self-administer medications safely and accurately. The well-developed healthcare ecosystem and patient-centric approach in North America contribute to the dominance of this segment.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Wearable Injectors Market
Buy Now GET FREE SAMPLE
Automotive Injector Nozzle Market
Buy Now GET FREE SAMPLE
Facial Injectables Market
Buy Now GET FREE SAMPLE
Injection Pen Market
Buy Now GET FREE SAMPLE
Lyophilized Injectable Drugs Market
Buy Now GET FREE SAMPLE
Infusion Pump Market
Buy Now GET FREE SAMPLE
Gasoline Direct Injection System Market
Buy Now GET FREE SAMPLE
Intravenous Infusion Pump Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global auto injector Market

Report ID: SQMIG35B2104

$5,300
BUY NOW GET FREE SAMPLE